SET Nuclear Oncogene (SET) Peptide
SET
Reactivité: Mammifères
Hôte: Synthetic
BP, IHC, WB
N° du produit ABIN939297
Aperçu rapide pour SET Nuclear Oncogene (SET) Peptide (ABIN939297)
Antigène
SET/TAF-I (SET)
(SET Nuclear Oncogene (SET))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Type de proteíne
- Synthetic
-
Séquence
- IDEVQNEIDR LNEQASEEIL KVEQKYNKLR QPFFQKRSEL IAKIPNFWVT
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SET antibody,
Alternative Names: SET control peptide, SET antibody Blocking Peptide, Anti-SET Blocking Peptide, Set Nuclear Oncogene Blocking Peptide, 2PP2A Blocking Peptide, I2PP2A Blocking Peptide, IGAAD Blocking Peptide, PHAPII Blocking Peptide, TAF-IBETA Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Sujet
- SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1.
-
Poids moléculaire
- 32 kDa
Antigène
-
Vous êtes ici:
